https://the483.com/amgen-300m-puerto-rico-biologics/ The 483 en 2026-05-04T22:25:18.000Z Amgen Adds $300M to Puerto Rico Biologics Site https://the483.com/gamestop-ebay-bid-55b-gap/ The 483 en 2026-05-04T21:43:11.512Z Bid $55.5B for eBay: GameStop Can't Cover It https://the483.com/astrazeneca-camizestrant-odac-9-month-adcomm/ The 483 en 2026-05-04T21:28:04.000Z ODAC Rejects AstraZeneca Camizestrant 6-3 After 9 Months https://the483.com/shinyhunters-instructure-canvas-data-breach/ The 483 en 2026-05-04T20:34:21.000Z ShinyHunters Steals 275M Instructure Canvas Records https://the483.com/windward-bio-165m-phase-3-asthma/ The 483 en 2026-05-04T20:05:41.233Z Windward Bio Raises $165M for Late-Stage Trial https://the483.com/ucb-candid-2b-t-cell-engager/ The 483 en 2026-05-04T16:38:49.000Z Ken Song's T Cell Engager Bet Gets Picked Up https://the483.com/pfizer-arvinas-veppanu-first-protac/ The 483 en 2026-05-04T15:45:58.000Z FDA Clears Pfizer-Arvinas Veppanu as First PROTAC https://the483.com/ucb-candid-2b-gilead-tce/ The 483 en 2026-05-04T14:50:04.000Z Bought Candid for $2B, UCB Challenges Gilead on TCE https://the483.com/celcuity-gedatolisib-beats-piqray-phase-3/ The 483 en 2026-05-04T13:55:09.971Z Celcuity Beats Piqray in Phase 3, Shares Jump 15% https://the483.com/defender-digicert-cert-false-positive/ The 483 en 2026-05-03T22:17:56.000Z Defender Pulls DigiCert Root Certs in False-Positive Hit https://the483.com/instructure-canvas-criminal-breach-second/ The 483 en 2026-05-03T15:19:01.000Z Instructure Hit by Second Breach in Eight Months https://the483.com/arvinas-veppanu-first-protac-approved/ The 483 en 2026-05-03T14:23:14.000Z FDA Clears Arvinas' Veppanu, First PROTAC Drug https://the483.com/novartis-23b-nc-api-plant/ The 483 en 2026-05-02T23:19:24.000Z Novartis Seals $23B US Build With NC API Plant